University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found ...

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said on ...

University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects ...

Infants randomized to the 9-month age group were then further randomized in a 2:1 ratio to receive a single dose of the investigational meningococcal vaccine Men5CV (brand name MenFive ...

Immune responses against serogroups A, C, W, and Y were noninferior between the MenABCWY and MenACWY-CRM vaccines in young adults and adolescents.

Doctors share concerns over how declining rates of vaccinations could put people at risk for Meningococcal disease and Measles.

The US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.

Penmenvy protects against meningococcal serotypes A, B, C, W and Y. CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent ...

Fortunately, a vaccine can protect against this disease and its more serious consequences. The meningococcal vaccine can help protect against different versions of disease caused by Neisseria ...